Top Markets
Coin of the day
TaiwanJ Pharmaceuticals Co., Ltd. TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd.

6549
Clasificación en acciones #30195
TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm... TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's comprehensive product portfolio is engineered to combat a wide array of diseases, encompassing hepatic inflammation and fibrosis, non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), various autoimmune disorders, asthma, and atopic dermatitis (eczema). Established in 2011, the company's operations are headquartered in Zhubei, Taiwan.
Precio por acción
$0.22227521
Capitalización bursátil
$17.81M
Cambio (1 día)
0.00%
Cambio (1 año)
-14.81%
País
TW
Comercio TaiwanJ Pharmaceuticals Co., Ltd. (6549)

Categoría

Historial del precio de la acción de TaiwanJ Pharmaceuticals Co., Ltd. (6549)
Precio más alto de cierre: $0.22 el 2026-08-01

Precio más bajo de cierre: $1.48 el 2015-10-01
Historial del precio de la acción de TaiwanJ Pharmaceuticals Co., Ltd. desde 2015 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -0.02%
2025 -4.42%
2024 -46.55%
2023 39.35%
2022 -2.83%
2021 -22.13%
2020 32.12%
2019 63.58%
2018 -45.16%
2017 -41.89%
2016 -53.24%
2015 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$527.89 35.09%
US
$996.61 51.72%
NL
$116.99 -19.63%
AU
$735.86 6.07%
CH
$257.75 14.92%
BE